Bruker Corp (NAS:BRKR)
$ 75.07 -0.75 (-0.99%) Market Cap: 10.91 Bil Enterprise Value: 12.03 Bil PE Ratio: 27.30 PB Ratio: 7.71 GF Score: 96/100

Bruker Corp at JPMorgan Healthcare Conference Transcript

Jan 13, 2020 / 07:30PM GMT
Release Date Price: $53 (+2.08%)
Ruizhi Qin
JP Morgan Chase & Co, Research Division - Analyst

Good morning, everyone. Welcome to day 1 of the JPMorgan Health Care Conference. I'm Julia Qin. I work on the life science tools and diagnostics scheme at JPMorgan. It's my great pleasure to introduce you to our next company session by Bruker. As a reminder, the breakout session is in the Sussex room.

And with that, I'll turn it over to Frank. Welcome.

Frank H. Laukien
Bruker Corporation - Chairman, CEO & President

Thank you very much for the introduction. It's a pleasure to be here on day 1 when everybody is smiling and all relaxed. Thank you very much for being here today, ladies and gentlemen. I'm here with members of our management team, Miroslava Minkova, who runs our Corporate Development and Investor Relations; and of course, our CFO, who will also give you a bit of a financial and debt restructuring update. So he and I will -- Gerald and I will share this presentation a little bit. I would also like to acknowledge some of my directors and colleagues -- management colleagues

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot